Logo image of ALCYB.PA

CYBERGUN SA (ALCYB.PA) Stock Fundamental Analysis

Europe - EPA:ALCYB - FR0014004QR6 - Common Stock

0.0004 EUR
0 (-20%)
Last: 8/1/2025, 7:00:00 PM
Fundamental Rating

1

Overall ALCYB gets a fundamental rating of 1 out of 10. We evaluated ALCYB against 16 industry peers in the Leisure Products industry. ALCYB may be in some trouble as it scores bad on both profitability and health. ALCYB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALCYB had negative earnings in the past year.
ALCYB had a negative operating cash flow in the past year.
In the past 5 years ALCYB reported 4 times negative net income.
ALCYB had a negative operating cash flow in each of the past 5 years.
ALCYB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCYB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

1.2 Ratios

ALCYB has a worse Return On Assets (-27.57%) than 85.71% of its industry peers.
ALCYB has a Return On Equity of -107.44%. This is amonst the worse of the industry: ALCYB underperforms 85.71% of its industry peers.
Industry RankSector Rank
ROA -27.57%
ROE -107.44%
ROIC N/A
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A
ALCYB.PA Yearly ROA, ROE, ROICALCYB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

With a Gross Margin value of 40.24%, ALCYB perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Gross Margin of ALCYB has grown nicely.
ALCYB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%
ALCYB.PA Yearly Profit, Operating, Gross MarginsALCYB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

ALCYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCYB has more shares outstanding
ALCYB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALCYB is higher compared to a year ago.
ALCYB.PA Yearly Shares OutstandingALCYB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ALCYB.PA Yearly Total Debt VS Total AssetsALCYB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.10, we must say that ALCYB is in the distress zone and has some risk of bankruptcy.
ALCYB has a Altman-Z score of -0.10. This is amonst the worse of the industry: ALCYB underperforms 85.71% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that ALCYB is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.13, ALCYB belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -0.1
ROIC/WACCN/A
WACC5.25%
ALCYB.PA Yearly LT Debt VS Equity VS FCFALCYB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.01 indicates that ALCYB should not have too much problems paying its short term obligations.
ALCYB has a worse Current ratio (1.01) than 78.57% of its industry peers.
A Quick Ratio of 0.44 indicates that ALCYB may have some problems paying its short term obligations.
ALCYB has a worse Quick ratio (0.44) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.44
ALCYB.PA Yearly Current Assets VS Current LiabilitesALCYB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

ALCYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3372.58%.
The Revenue has decreased by -1.46% in the past year.
Measured over the past years, ALCYB shows a small growth in Revenue. The Revenue has been growing by 5.94% on average per year.
EPS 1Y (TTM)-3372.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.89%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-15.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALCYB.PA Yearly Revenue VS EstimatesALCYB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ALCYB.PA Yearly EPS VS EstimatesALCYB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 0 5M -5M -10M -15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALCYB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCYB.PA Price Earnings VS Forward Price EarningsALCYB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCYB.PA Per share dataALCYB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALCYB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYBERGUN SA

EPA:ALCYB (8/1/2025, 7:00:00 PM)

0.0004

0 (-20%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)10-31 2024-10-31
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.89M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.57%
ROE -107.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.24%
FCFM N/A
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.45%
Cap/Sales 1.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.44
Altman-Z -0.1
F-Score4
WACC5.25%
ROIC/WACCN/A
Cap/Depr(3y)164.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.65%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3372.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-15.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-495.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.3%
OCF growth 3YN/A
OCF growth 5YN/A